Alabama Hospital Bacterial Infections Linked to Contaminated IV Bags

|

Federal drug regulators indicate that unsanitary conditions at a specialty pharmacy in Alabama led to a bacterial outbreak in several local hospitals, which may have contributed to the death of at least nine people. 

The FDA sent a warning letter to Advanced Specialty Pharmacy, an Alabama pharmacy that was doing business as Meds IV last year when its Total Parentaral Nutrition IV bags were linked to a deadly bacterial outbreak. The letter indicates that the FDA believes that the recalled IV drugs were prepared, packed or held in unsanitary conditions and may have been “contaminated with filth.”

The fact that the drugs were contaminated and sold to the public means they were misbranded as safe, according to the FDA’s letter. Bacteria identical to that which killed and sickened patients was found on faucets inside the production facility.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

In March 2011, Meds IV, an Alabama compounding pharmacy shut their doors and issued a recall for IV bags that contained a liquid nutrient known as Total Parenteral Nutrition (TPN). 

The  recall was issued after an outbreak of infections involving Serratia marcescens bacteria were identified at six different Alabama hospitals where the IV bags were used. Several hospital infection lawsuits were filed as a result.

The Alabama hospitals known to have received the tainted IV bags include Baptist Princeton, Baptist Shelby, Baptist Prattville, Medical West, Cooper Green Mercy and Select Specialty Hospital in Birmingham.

The FDA acknowledges that the company has surrendered its pharmacy license as a result of the incident. If the company were ever attempt to reopen, it would have to tell the FDA at least 15 days ahead of time, explaining how it would prevent a similar outbreak.

Serratia marcescens is a waterborne bacteria that can cause fever, respiratory problems and shock.  The Alabama Department of Public Health investigators found bacteria on a faucet and medical equipment at the Meds IV lab.  The company has since decided to cease operations and officials with the Centers for Disease Control and Prevention (CDC) have indicated that it is unlikely the business will reopen.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation.
Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court.
The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution.